Drugstores Report Increased Prescriptions for Medicare Obesity Drug Program

Why it matters locally: Vermont's elderly population, which accounts for a significant portion of the state's demographics, will be directly affected by increased access to obesity medications through the Medicare Bridge program. This federal initiative could impact healthcare costs and access for Medicare beneficiaries in the state.

---

Drugstore chains CVS and Walgreens have each dispensed 100,000 prescriptions under a new Medicare initiative. The program, known as Bridge, launched on July 1. It provides certain Medicare beneficiaries access to obesity medications for a monthly cost of $50. The Bridge program aims to increase access to specific obesity drugs for eligible Medicare participants. CVS and Walgreens began processing these prescriptions shortly after the program's implementation.